Base excision repair-mediated resistance to cisplatin in KRAS(G12C) mutant NSCLC cells.
Caiola E, Salles D, Frapolli R, Lupi M, Rotella G, Ronchi A, Garassino MC, Mattschas N, Colavecchio S, Broggini M, Wiesmüller L, Marabese M.
Caiola E, et al.
Oncotarget. 2015 Oct 6;6(30):30072-87. doi: 10.18632/oncotarget.5019.
Oncotarget. 2015.
PMID: 26353932
Free PMC article.